Autopsy report · NCT00808626

Phase II Investigation of 99mTc-rBitistatin for Imaging Venous Thrombosis

“Lack of funding to complete trial. A lead member of research team retired.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1, Phase 2

Sponsor

Temple University

Sponsor type

University, hospital or other

Conditions

Venous Thrombosis

Interventions

99mTc-rBitistatin

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Safety and Effectiveness of Combined LED Light for the Treatment of Mild to Moderate Plaque Type Psoriasis Vulgaris
  “Lack of funding and sponsor decided to not pursue clinical trial” (74% match in meaning)
• Efficacy, Tolerability and Acceptability of Biktarvy by TPLWH
  “Trial set up was delayed, funding support no longer available” (68% match in meaning)
• DELP for Acute Hemorrhagic Stroke
  “the research sponsors stopped further funding due to a planning of a multi-center trial” (67% match in meaning)
• Pancreatic Enzyme Supplementation for Celiac Disease
  “The trial was terminated prematurely by the sponsor for administrative reasons.” (67% match in meaning)
• P Gingivalis Oral Infection, Intimamedia Thickening in Infants, Atherosclerosis
  “Grant not funded so clinical trial not started.” (67% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.